Jeonjinbio Co. Ltd (110020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million ≈ $212.26K USD) by net assets (₩17.72 Billion ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jeonjinbio Co. Ltd stock valuation for the company's overall valuation and market capitalisation.

Jeonjinbio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency. Explore how high is Jeonjinbio Co. Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Surana Solar Limited
NSE:SURANASOL
0.116x
OPG POWER VENTURES (OPB.SG)
STU:OPB
N/A
See Hup Consolidated Bhd
KLSE:7053
0.028x
ShreeOswal Seeds And Chemicals Limited
NSE:OSWALSEEDS
0.007x
Malpac Holdings Bhd
KLSE:4936
0.000x
Clean & Science co. Ltd
KQ:045520
0.147x
Samyoung S&C Co. Ltd.
KQ:361670
-0.051x
Equus Total Return Closed Fund
NYSE:EQS
0.000x

Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. View Jeonjinbio Co. Ltd (110020) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩17.66 Billion
≈ $11.97 Million
₩3.01 Billion
≈ $2.04 Million
0.170x +452.06%
2023-12-31 ₩6.22 Billion
≈ $4.21 Million
₩-300.60 Million
≈ $-203.71K
-0.048x +87.61%
2022-12-31 ₩9.51 Billion
≈ $6.44 Million
₩-3.71 Billion
≈ $-2.51 Million
-0.390x -76.65%
2021-12-31 ₩10.80 Billion
≈ $7.32 Million
₩-2.38 Billion
≈ $-1.62 Million
-0.221x -7.88%
2020-12-31 ₩11.28 Billion
≈ $7.65 Million
₩-2.31 Billion
≈ $-1.57 Million
-0.205x +54.32%
2019-12-31 ₩2.90 Billion
≈ $1.96 Million
₩-1.30 Billion
≈ $-880.34K
-0.448x +18.90%
2018-12-31 ₩3.91 Billion
≈ $2.65 Million
₩-2.16 Billion
≈ $-1.46 Million
-0.553x +69.24%
2017-12-31 ₩229.96 Million
≈ $155.84K
₩-413.19 Million
≈ $-280.01K
-1.797x -2154.30%
2016-12-31 ₩2.28 Billion
≈ $1.55 Million
₩-181.90 Million
≈ $-123.27K
-0.080x +94.83%
2015-12-31 ₩1.27 Billion
≈ $858.87K
₩-1.95 Billion
≈ $-1.32 Million
-1.541x --

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals
Market Cap
$13.57 Million
₩20.02 Billion KRW
Market Cap Rank
#26374 Global
#1989 in Korea
Share Price
₩2210.00
Change (1 day)
+3.03%
52-Week Range
₩1641.00 - ₩3025.00
All Time High
₩16700.00
About

Jeonjinbio Co., Ltd. develops and produces natural bio-pesticides, alternative chemical products, and other biotechnology products. The company offers repellent for bird, boar, rodent, snake, and sea lice; and dress perfume, including Paris 16e, Paris 16e Bouquet, Bouquet Garni, and Bridcan, as well as mosquito repellent. It also provides laundry products. Jeonjin Bio Co., Ltd. was founded in 200… Read more